2007
DOI: 10.1016/s1098-3015(10)65196-0
|View full text |Cite
|
Sign up to set email alerts
|

Pcn38 Cost-Analysis of Xeloxvs. Folfox-4 ± Bevacizumab (Bev) in Metastatic Colorectal Cancer (Mcrc) in an Italian Hospital Setting

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2013
2013
2013
2013

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 0 publications
0
0
0
Order By: Relevance